Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS
Publication date
2020-10-01
Authors
Ossenkoppele, G. J.
Breems, D. A.
Stuessi, G.
van Norden, Y.
Bargetzi, M.
Biemond, B. J.
A von dem Borne, P.
Chalandon, Y.
Cloos, J.
Deeren, D.
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
taverne
Abstract
Correction to: Leukemia https://doi.org/10.1038/s41375-020-0725-0
Keywords
Taverne, Hematology, Oncology, Cancer Research
Citation
Ossenkoppele, G J, Breems, D A, Stuessi, G, van Norden, Y, Bargetzi, M, Biemond, B J, A von dem Borne, P, Chalandon, Y, Cloos, J, Deeren, D, Fehr, M, Gjertsen, B T, Graux, C, Huls, G, Janssen, J J W M, Jaspers, A, Jongen-Lavrencic, M, de Jongh, E, Klein, S K, van der Klift, M, van Marwijk Kooy, M, Maertens, J A, Michaux, L, van der Poel, M W M, Van Rhenen, A, Tick, L, Valk, P, Vekemans, M C, van der Velden, W J F M, de Weerdt, O, Pabst, T, Manz, M, Löwenberg, B, Breems, D A, Havelange, Vekemans, M C, Moors, I, van Obberg, F, Maertens, J A, Hodossy, B, Vansteenweghen, S, Lammertijn, L, Deeren, D, Klein, S K, Janssen, J J W M, Brouwer, R E, Schouten, H C, de Weerdt, O, Kuball, J, Van Rhenen, A & for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) 2020, 'Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS', Leukemia, vol. 34, no. 10, pp. 2820-2820. https://doi.org/10.1038/s41375-020-0994-7